Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 13, 2018
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
Liisa Bayko Maintained (VRTX) at Buy with Increased Target to $211 on, Feb 13th, 2018
Liisa Bayko of JMP Securities, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $200 to $211 on, Feb 13th, 2018.
Liisa has made no other calls on VRTX in the last 4 months.
There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Liisa's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Liisa
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Friday, February 2nd, 2018
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $197 on, Thursday, February 1st, 2018
- Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $191 on, Thursday, February 1st, 2018
- Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $200 on, Thursday, February 1st, 2018
